{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:15:21Z","timestamp":1783973721919,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humpath.2022.12.005","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:22:53Z","timestamp":1671502973000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-5538","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Lenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lie","family":"Klub\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Pt\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"H\u00e1jkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"\u0160teiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Kinkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1n","family":"\u0160vajdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Mach\u00e1\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Hurn\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tich\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franti\u0161ek","family":"Tich\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kyllar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Kavka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.12.005_bib1","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1002\/cncr.23978","article-title":"Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy","volume":"113","author":"Drilon","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.12.005_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/106689690301100215","article-title":"Poorly differentiated extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q11) translocation presenting initially as a solid variant devoid of myxoid areas","volume":"11","author":"Reid","year":"2003","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2559.1999.00735.x","article-title":"High-grade extraskeletal myxoid chondrosarcoma: a high-grade epithelioid malignancy","volume":"35","author":"Lucas","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.12.005_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0046-8177(95)90196-5","article-title":"Myxoid chondrosarcoma of soft tissue and bone: a retrospective study of 11 cases","volume":"26","author":"Abramovici","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1440-1827.2005.01853.x","article-title":"Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics","volume":"55","author":"Hisaoka","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2022.12.005_bib6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e318161781a","article-title":"SMARCB1\/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1\/INI1 negative variant extraskeletal myxoid chondrosarcoma","volume":"32","author":"Kohashi","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/modpathol.2017.189","article-title":"INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma","volume":"31","author":"Yoshida","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/PAS.0000000000001109","article-title":"EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic\/myofibroblastic neoplasms","volume":"42","author":"Michal","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00428-020-02774-z","article-title":"Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor","volume":"477","author":"Michal","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.12.005_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2019.02.009","article-title":"Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases","volume":"88","author":"\u0160vajdler","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib11","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1016\/S0021-9258(18)42173-4","article-title":"A novel human insulinoma-associated cDNA, IA-1, encodes a protein with \"zinc-finger\" DNA-binding motifs","volume":"267","author":"Goto","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2022.12.005_bib12","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1074\/jbc.M808843200","article-title":"Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2022.12.005_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib14","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.ajpath.2015.08.018","article-title":"Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung cancer","volume":"185","author":"Fujino","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00000478-200007000-00015","article-title":"Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2)","volume":"24","author":"Harris","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1053\/hupa.2001.28226","article-title":"Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases","volume":"32","author":"Okamoto","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880161","article-title":"Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases","volume":"13","author":"Oliveira","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib18","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/en.2007-1202","article-title":"The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle","volume":"149","author":"Pearen","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.humpath.2022.12.005_bib19","doi-asserted-by":"crossref","first-page":"33467","DOI":"10.1074\/jbc.M603436200","article-title":"The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation","volume":"281","author":"Nomiyama","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2022.12.005_bib20","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1038\/sj.onc.1203156","article-title":"Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma","volume":"18","author":"Attwooll","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2022.12.005_bib21","first-page":"5064","article-title":"Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma","volume":"59","author":"Sj\u00f6gren","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.005_bib22","first-page":"765","article-title":"t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases","volume":"8","author":"Sciot","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/gcc.20044","article-title":"TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma","volume":"40","author":"Hisaoka","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2022.12.005_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/gcc.22976","article-title":"SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing","volume":"60","author":"Wei","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2022.12.005_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.humpath.2014.01.007","article-title":"Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology","volume":"45","author":"Agaram","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jmoldx.2013.12.002","article-title":"Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma","volume":"16","author":"Benini","year":"2014","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2022.12.005_bib27","first-page":"6832","article-title":"Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21)","volume":"60","author":"Sj\u00f6gren","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.005_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cancergencyto.2003.11.011","article-title":"Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes","volume":"152","author":"Hisaoka","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2022.12.005_bib29","series-title":"WHO classification of tumours editorial board. Soft tissue and bone tumours","first-page":"303","article-title":"Extraskeletal myxoid chondrosarcoma","author":"Horvai","year":"2020"},{"key":"10.1016\/j.humpath.2022.12.005_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000478-199906000-00002","article-title":"Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases","volume":"23","author":"Meis-Kindblom","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.005_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.14339","article-title":"DNA damage-inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression","volume":"79","author":"Vargas","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.12.005_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/gcc.22835","article-title":"A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements","volume":"59","author":"Suurmeijer","year":"2020","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:10Z","timestamp":1758645670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"alternative-id":["S0046817722002830"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}